Skip to content

A Comparative Clinical Study to Assess the Effectiveness of Manjistha Lepa and Krishna Mrittika Lepa in the Management of Vyanga (Facial Hyperpigmentation / Melasma)

A comparative clinical study to evaluate the efficacy of manjistha lepa and krishna mrittika lepa in vyanga - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104632
Enrollment
60
Registered
2026-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L814- Other melanin hyperpigmentation

Interventions

None listed

Sponsors

Office of principal Shri Narayan Prasad Awasthi Government Ayurved College,Raipur Chattisgarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age- 18-50 years Gender- Both male and female Patients with classical symptom of Vyanga Mukhamagatya Mandal, nirujam, tanukamsyav.

Exclusion criteria

Exclusion criteria: Those whose age is less than 18 years and more than 50 years In case of repeated occurrence of Urticaria. Infectious diseases like eg-herpes, fungal infection, In case of any kind of allergy in the skin skin cancer patients Accidental injury in mark Birth marks Any history of hypersensitivity to cream or lotion, Lepa. In pregnancy. Any present or past history of skin disease eg. Psoriasis , Vitiligo, Dermatitis. Person with endocrinal disorder like Cushing , Addisons disease, Acne Vulgaris.

Design outcomes

Primary

MeasureTime frame
Manjistha lepa and Krishna mritika lepa are effective in Vyanga. Timepoint: Manjistha lepa and Krishna mritika lepa are effective in Vyanga.

Secondary

MeasureTime frame
Manjistha lepa is more effective in Vyanga. Krishna Mrittika lepa is more effective in Vyanga.Timepoint: 3 months

Countries

India

Contacts

Public ContactDr Vibha Pali

Narayan Prasad Awasthi govt ayurvedic College raipur

vibhapali@gmail.com9827489369

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026